Elisabeth Rosenthal - KFF Health News
-
Convenient as it may be, beware of getting your blood drawn at a hospital. As one Texas woman discovered, the cost could be higher than at an independent lab, and your insurance might not cover it.
-
The CDC’s RSV vaccination recommendations beg the question: How much should an immunization that will possibly be given to millions of Americans cost to be truly valuable?
-
The declining share of U.S. doctors in adult primary care is about 25% — a point beyond which many Americans won’t be able to find a family doctor at all.
-
Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development nor their therapeutic value, research shows.
-
After decades of unchecked mergers, health care is the land of giants, with huge medical systems monopolizing care in many cities, states, and even whole regions of the country.
-
HHS is tasked with monitoring denials both by ACA plans and those offered through employers and insurers. As ’ denials become more common, they sometimes defy not just medical standards but sheer logic. Why hasn’t the agency fulfilled its assignment?
-
Given a dire shortage of behavioral health providers in the U.S., it may prove tempting for insurers to offer up apps and chatbots to meet the federal mental health parity requirement.
-
Perspective: Amid skyrocketing drug prices, it’s understandable that patients desperately need help affording medicine, especially when their health is on the line. But these programs create a mirage that perpetuates our health care system’s reckless spending.
-
When insurance firms wouldn't pay, a woman facing a large tab for her newborn's ICU treatment was given a chance to pay $45,843 a month for a year. The story changed when a reporter got on the line.
-
Federal, state and municipal governments as well as private businesses continue to largely avoid mandates out of fears they will provoke a backlash. So, how about an economic argument?